NIDEC PHARMA
Last board
2 directors, 2 in day-to-day management, last change in 2023Managing director
in office according to the deed of 12-10-2023
also on the board of 1 other company
listed in the 2023 annual accounts, filed on 22-08-2024
Managing director, permanent representative
managing director in office according to the deed of 12-10-2023
managing director in office according to the deed of 08-08-2017
listed in the 2023 annual accounts, filed on 22-08-2024
- ,
Permanent representatives 1
Permanent representative, for
in office according to the deed of 12-10-2023
also on the board of 1 other company
Mandates through the years
2 names, the dashed line is todayManaging director, Director
Director, Managing director
LeadershipBoardmandate already running before its first mention
Mandates as a list
-
- Managing director, since before 12-06-2017
- Director, since before 08-08-2017
-
- Director, since before 08-08-2017
- Managing director, since before 12-06-2023
Control
Parent
Equity €344,187
Loss €58,202 in 2025 (loss €33,669 in 2024)
Checked score
Source: deed 28-02-2024
100%
This company
NIDEC PHARMA
Equity -€572,157
Profit €62,618 in 2023
Capital
- Capital
- €61,973.38
- Source
- 2023 annual accounts
Owners through the years
as the annual accounts name themOwners as a list
-
- 2011 to 2023: 100%
Source: lists of holdings in the owners' accounts
Capital transactions
Shareholders according to the deeds
Stated in the deed
deed of 08-05-2024 ↗
- all shares
Stated in the deed
deed of 28-02-2024 ↗
- all shares · 100%